Free Delivery Over $100
|
|
|||
|
||||
OverviewKatharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. – as early knower – have the most projects as well as personalized drugs and therapies, while Germany – as a follower – has a significant number of projects and personalized products and more to come in future. Full Product DetailsAuthor: Katharina KichkoPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer Gabler Edition: 1st ed. 2019 Weight: 0.496kg ISBN: 9783658278427ISBN 10: 3658278420 Pages: 354 Publication Date: 26 September 2019 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsPersonalized Medicine Background.- The United States of America as Early Knower.- Germany as Follower.- Further Implementation of Personalized Medicine in Germany Based on Learnings from the U.S.ReviewsAuthor InformationKatharina Kichko has written this book within her PhD program at the University of Greifswald. Tab Content 6Author Website:Countries AvailableAll regions |
||||
